Palmer's Amaranth Allergy: A Major Tumbleweed Pollen in the Arid West
Palmer's amaranth (Amaranthus palmeri) is a highly aggressive tumbleweed and one of the most clinically significant weed pollen allergens in the US Southwest, Southern Plains, and increasingly the Southeast. It produces copious airborne pollen from late summer through fall, triggering severe hay fever and asthma exacerbations. Sensitization rates in arid regions can exceed 30% among atopic patients. Management includes avoidance, pharmacotherapy, and allergen immunotherapy, which is the only disease-modifying treatment.
Free · 5 min · Insurance accepted
What Is Palmer's Amaranth Allergy?
Palmer's amaranth (Amaranthus palmeri) is a summer annual weed in the Amaranthaceae family that has become one of the most aggressive and economically damaging agricultural weeds in North America — and a major driver of fall hay fever across the southern United States.
Unlike common amaranth species that are primarily insect-pollinated, Palmer's amaranth is a prolific wind-pollinator, releasing enormous quantities of lightweight pollen grains that travel long distances on the wind. A single male plant can produce hundreds of thousands of pollen grains, creating high ambient pollen counts in agricultural regions where the plant has become dominant.
Native to the Sonoran Desert and southwestern US, Palmer's amaranth has spread aggressively eastward into the Southern Plains, the Mississippi Delta, and the southeastern states, largely driven by herbicide resistance in cotton and soybean cropping systems. For allergy patients, this means that what was once a regional allergen of the arid Southwest is now a relevant fall pollen across much of the southern half of the United States. The plant is a tumbleweed — at maturity, the entire above-ground structure detaches and rolls in the wind, dispersing seed and residual pollen over wide areas.
Symptoms of Palmer's Amaranth Allergy
Recognizing symptoms early helps you get the right treatment faster.
Paroxysmal sneezing
moderateSudden, repetitive sneezing fits triggered by inhaled amaranth pollen are a hallmark of sensitization; often most severe during outdoor exposure in late summer and fall.
Severe nasal congestion
moderateIntense mucosal swelling from histamine release causes significant nasal blockage; may be refractory to oral antihistamines alone and require intranasal corticosteroids.
Watery rhinorrhea
moderateProfuse, clear nasal discharge is characteristic of the early-phase allergic response and can be socially disabling during peak pollen exposure.
Intense ocular itching and burning
moderateAmaranth pollen is a potent conjunctival irritant; patients often describe eye symptoms as the most bothersome feature, with itching, redness, and tearing that may not fully respond to oral antihistamines.
Palatal and pharyngeal itch
mildDeep itching of the soft palate and throat is a classic feature of pollen allergy, often described as an 'itch that can't be scratched' and distinct from infectious pharyngitis.
Postnasal drip and cough
mildExcess mucus production draining into the pharynx triggers chronic throat clearing and cough, particularly at night when recumbent.
Asthma exacerbation
severeInhaled amaranth pollen can trigger bronchospasm in sensitized asthmatics; wheezing, chest tightness, and shortness of breath during the fall pollen season warrant prompt medical evaluation.
Fatigue and impaired concentration
mildChronic nasal congestion and poor sleep quality from nighttime symptoms lead to daytime fatigue, reduced productivity, and 'brain fog' during the prolonged fall pollen season.
When to see a doctor
Palmer's amaranth pollen allergy produces the full spectrum of IgE-mediated allergic rhinitis and conjunctivitis symptoms, and because of the high pollen output and long season, symptoms can be particularly severe and persistent. The classic presentation includes paroxysmal sneezing, profuse watery rhinorrhea, severe nasal congestion, and intense ocular itching — often described by patients as the worst allergy season of the year, worse even than spring tree or grass pollen seasons. A distinguishing clinical feature of Amaranthaceae pollen allergy is the severity of ocular symptoms. Patients frequently report intense eye itching, burning, and swelling that is poorly controlled by oral antihistamines alone. The small pollen grain size of Amaranthus species (20–30 microns) allows deep penetration into the nasal passages and conjunctiva. Given the high cross-reactivity within the Amaranthaceae family, patients sensitized to Palmer's amaranth may also react to Russian thistle, lamb's quarters, and other related weeds — effectively extending the symptomatic season from late summer through the first hard freeze. If you experience throat tightness, wheezing, or difficulty breathing during the fall pollen season, seek medical evaluation promptly, as these may indicate asthma exacerbation requiring escalation of therapy.
Palmer's Amaranth and Asthma Risk
The link between Amaranthaceae pollen allergy and asthma is well established in the clinical literature. Weed pollen allergens, including those from Amaranthus species, are recognized triggers of both seasonal allergic asthma exacerbations and, in the context of prolonged untreated allergic rhinitis, contributors to the development of persistent asthma. The atopic march — the progression from allergic rhinitis to asthma — is particularly relevant for patients with severe, prolonged weed pollen allergy, as the chronic airway inflammation driven by months of continuous pollen exposure can promote bronchial hyperresponsiveness. Patients with known asthma who live in regions with high Palmer's amaranth pollen counts should work with their allergist to optimize asthma control before the August–November season begins, as this is the highest-risk window for weed pollen-triggered exacerbations.
Potential Complications of Palmer's Amaranth Allergy
Untreated or undertreated Palmer's amaranth pollen allergy can lead to several clinically significant complications. The prolonged fall pollen season — often 3–4 months in warmer regions — means that chronic nasal and sinus inflammation persists far longer than with shorter spring pollen seasons, increasing the risk of secondary bacterial sinusitis. Recurrent sinus infections may require antibiotic treatment and, in refractory cases, surgical intervention to restore sinus drainage. Sleep disturbance from nocturnal nasal congestion is a frequently underappreciated complication. Patients with severe amaranth allergy often report poor sleep quality, daytime somnolence, and reduced cognitive performance during the fall months — symptoms that can impair work productivity and quality of life. The profilin allergen Ama r 2 may also drive oral allergy syndrome with raw plant foods, adding dietary restrictions to the clinical burden. Most importantly, chronic untreated allergic rhinitis from weed pollen is a significant risk factor for the development of new-onset asthma, particularly in children and young adults.
Chronic or recurrent sinusitis
Persistent nasal inflammation impairs sinus drainage, creating conditions favorable for bacterial superinfection; recurrent sinusitis may require prolonged antibiotic courses or surgical management.
Sleep disturbance and daytime impairment
Nocturnal nasal congestion disrupts sleep architecture, leading to daytime fatigue, impaired concentration, and reduced quality of life during the prolonged fall pollen season.
Asthma development or worsening
Chronic allergic airway inflammation is a well-established risk factor for asthma onset in atopic individuals and for exacerbation of existing asthma.
Oral allergy syndrome (profilin-mediated)
Patients sensitized to the profilin Ama r 2 may experience oral tingling and lip swelling with raw melons, celery, and other profilin-containing plant foods.
Reduced quality of life during peak season
Severe, prolonged symptoms during the August–November window can significantly impair work performance, social activities, and overall well-being.
What Causes Palmer's Amaranth Allergy?
Palmer's amaranth allergy is a classic Type I IgE-mediated hypersensitivity to proteins present in the pollen grains of Amaranthus palmeri. The Amaranthaceae family includes several well-characterized allergenic weeds — notably Russian thistle (Salsola kali), lamb's quarters (Chenopodium album), and common pigweed (Amaranthus retroflexus) — and substantial cross-reactivity exists among these species. The major allergens characterized from Amaranthus species include Ama r 1 (a pectate lyase), Ama r 2 (a profilin), and Ama r 3 (a polcalcin). These proteins share structural homology with allergens from other Chenopodiaceae-Amaranthaceae weeds, meaning patients sensitized to one amaranth species are frequently co-sensitized to others.
Palmer's amaranth / carelessweed
Amaranthus palmeri
Redroot pigweed
Amaranthus retroflexus
Smooth pigweed
Amaranthus hybridus
Spiny amaranth
Amaranthus spinosus
Russian thistle (cross-reactive)
Salsola kali
How it works
Palmer's amaranth pollen allergy follows the standard Type I hypersensitivity pathway. During initial sensitization, the immune system of a genetically susceptible individual produces IgE antibodies specific to Amaranthus pollen proteins — primarily Ama r 1 (pectate lyase), Ama r 2 (profilin), and Ama r 3 (polcalcin). On subsequent exposure, inhaled pollen grains deposit on the nasal and conjunctival mucosa, where pollen proteins bind to IgE antibodies on the surface of mast cells. Cross-linking of adjacent IgE molecules triggers mast cell degranulation, releasing histamine, leukotrienes, and prostaglandins that produce the classic symptoms of allergic rhinitis and conjunctivitis within minutes. The profilin Ama r 2 is a pan-allergen that may also drive cross-reactivity with grass and tree pollens and some plant foods.
The clinical significance of Palmer's amaranth specifically — as distinct from other Amaranthus species — lies in its sheer pollen output and its expanding geographic range. In regions where it has become the dominant pigweed species (particularly herbicide-resistant populations in cotton and soybean country), it is the primary driver of Amaranthus pollen exposure. Sensitization rates among atopic patients in the US Southwest and Southern Plains have been reported at 15–30% on skin prick testing panels that include Amaranthus allergens.
Risk factors to watch for
Residence in the US Southwest or Southern Plains
Arizona, New Mexico, Texas, Oklahoma, and Kansas have the highest ambient Palmer's amaranth pollen exposure due to the plant's native range and agricultural dominance.
Residence in agricultural regions of the Southeast
Herbicide-resistant Palmer's amaranth has spread into cotton and soybean fields across the Mississippi Delta, Georgia, and the Carolinas, extending the allergen's geographic reach.
Existing Amaranthaceae sensitization
Patients already sensitized to Russian thistle, lamb's quarters, or other pigweed species are at high risk of cross-reactive sensitization to Palmer's amaranth.
Outdoor occupation or recreation in late summer/fall
Farmworkers, landscapers, and anyone spending significant time outdoors during the August–November pollen season faces higher cumulative exposure.
Personal or family history of atopy
A history of eczema, asthma, or other pollen allergies significantly increases the probability of developing Palmer's amaranth sensitization.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How Is Palmer's Amaranth Allergy Diagnosed?
Diagnosing Palmer's amaranth allergy begins with a detailed clinical history focused on the timing and geography of symptoms. A patient who reports severe, prolonged fall hay fever — worse than spring allergies — and who lives in or has traveled to the US Southwest, Southern Plains, or agricultural Southeast during August–November should raise suspicion for Amaranthaceae sensitization. The history should also explore whether symptoms correlate with outdoor activities, proximity to agricultural fields, or windy days when tumbleweeds are rolling. Skin prick testing with a regional weed pollen panel that includes Amaranthus species (often listed as 'carelessweed' or 'pigweed' on standard US panels) is the first-line diagnostic tool. A positive wheal-and-flare response to Amaranthus extract, in the context of a compatible clinical history, confirms sensitization. Specific IgE blood testing for Amaranthus pollen is also available through major reference laboratories. Because of the high cross-reactivity within the Amaranthaceae family, testing should also include Russian thistle and lamb's quarters to map the full sensitization profile. At-home allergy testing services such as Curex offer panels covering 40+ environmental allergens, including regionally relevant weed pollens, with results typically available within 5 days and insurance coverage often accepted — providing a convenient starting point for patients who want to identify their fall allergy triggers before scheduling an in-person allergist consultation.
Skin prick test with weed pollen panel
A standard regional weed panel including Amaranthus (carelessweed/pigweed), Russian thistle, and lamb's quarters can identify Amaranthaceae sensitization. A positive reaction to Amaranthus extract with a compatible fall symptom history is diagnostic.
Specific IgE blood testing (ImmunoCAP)
Serum IgE testing for Amaranthus pollen is available through commercial reference labs and can confirm sensitization without the need to stop antihistamines.
Nasal allergen provocation (research setting)
Controlled intranasal administration of amaranth pollen extract with measurement of symptom scores and nasal airflow; used primarily in clinical research rather than routine practice.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreatment Options for Palmer's Amaranth Allergy
See how different approaches stack up for managing your allergy symptoms long-term.
Treatment for Palmer's amaranth pollen allergy follows an evidence-based, stepwise approach that combines environmental controls, pharmacotherapy, and — for patients with moderate-to-severe symptoms — allergen immunotherapy. The prolonged fall pollen season (August–November in most regions) means that treatment must be sustained for months, not weeks, and pre-season initiation of controller medications significantly improves outcomes.
First-line pharmacotherapy for moderate-to-severe symptoms combines intranasal corticosteroids (for nasal congestion and rhinorrhea) with second-generation oral antihistamines (for sneezing and itch). For the intense ocular symptoms that characterize amaranth allergy, topical antihistamine eye drops often provide better relief than oral antihistamines alone. Patients with asthma should ensure their asthma action plan is optimized before the fall pollen season begins.
For patients whose symptoms are not adequately controlled by pharmacotherapy — or who wish to reduce long-term medication dependence — allergen immunotherapy targeting Amaranthus and cross-reactive Amaranthaceae weeds offers the only disease-modifying treatment. Both subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (allergy drops) can be formulated with amaranth extracts.
Pollen avoidance strategies
Limiting outdoor exposure during peak pollen hours (mid-morning to late afternoon), keeping windows closed, using HEPA air filtration indoors, and showering after outdoor activities reduce pollen load.
Not applicable
Partial symptom reduction; complete avoidance is impossible in high-exposure agricultural regions
Second-generation oral antihistamines
Non-sedating H1 receptor antagonists reduce sneezing, rhinorrhea, and itching; most effective when taken daily throughout the pollen season rather than as-needed.
Zyrtec (cetirizine), Claritin (loratadine), Allegra (fexofenadine), Xyzal (levocetirizine)
Clinical trials demonstrate 50–60% reduction in rhinitis symptom scores
Intranasal corticosteroids
First-line controller therapy for moderate-to-severe allergic rhinitis; reduces nasal mucosal inflammation, congestion, and rhinorrhea more effectively than antihistamines alone.
Flonase (fluticasone), Nasonex (mometasone), Nasacort (triamcinolone), Rhinocort (budesonide)
Meta-analyses show 30–40% greater symptom reduction compared to oral antihistamine monotherapy
Antihistamine eye drops
Topical ophthalmic antihistamines and mast cell stabilizers provide rapid, targeted relief for the intense ocular symptoms characteristic of amaranth pollen allergy.
Pataday (olopatadine), Alaway (ketotifen), Lastacaft (alcaftadine)
Rapid onset (within minutes); effective for itching, redness, and tearing refractory to oral antihistamines
Leukotriene receptor antagonists
Montelukast blocks leukotriene-mediated inflammation and may provide additional benefit for patients with concurrent asthma or those with nasal congestion poorly responsive to antihistamines and nasal steroids.
Singulair (montelukast)
Modest additional symptom control when added to antihistamine therapy; particular benefit in patients with allergic rhinitis and asthma
Allergen immunotherapy (SCIT or SLIT)
Subcutaneous or sublingual immunotherapy with Amaranthus and cross-reactive Amaranthaceae extracts provides long-term desensitization and is the only disease-modifying treatment for weed pollen allergy.
Custom-formulated Amaranthus and regional weed pollen extracts
Clinical trials demonstrate 60–80% reduction in symptom scores and medication use with sustained benefit after treatment completion
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for Palmer's Amaranth Pollen Allergy
Instead of masking symptoms, immunotherapy retrains your immune system.
For patients whose Palmer's amaranth allergy is not adequately controlled by avoidance and pharmacotherapy — or for those who wish to address the underlying immune sensitivity rather than managing symptoms season after season — allergen immunotherapy offers a disease-modifying alternative. Both subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (allergy drops) can be formulated with Amaranthus pollen extracts, typically as part of a regional weed pollen mix that also includes Russian thistle, lamb's quarters, and other cross-reactive Amaranthaceae species. The clinical rationale for immunotherapy in amaranth allergy is strong: the prolonged fall pollen season means patients endure months of symptoms annually, and the high cross-reactivity within the Amaranthaceae family means that desensitization to one member often confers benefit against related weeds. Sublingual immunotherapy drops, available through providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), allow patients to self-administer treatment at home without weekly clinic visits — a practical advantage for patients in rural agricultural regions where access to an allergist's office for weekly shots may be limited. Treatment typically spans 3–5 years, with most patients experiencing significant symptom reduction within the first 6–12 months. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026, peer-reviewed), clinically meaningful symptom improvement rose to 45% of patients by two years, quality-of-life improvement reached 90.7%, and adherence was over 90%, with no anaphylaxis reported.
Confirm sensitization profile
Skin prick testing or specific IgE blood work identifies Amaranthus sensitization and maps cross-reactive Amaranthaceae weeds to include in the immunotherapy formulation.
Custom extract formulation
An allergist prescribes a personalized immunotherapy extract containing Palmer's amaranth and relevant cross-reactive weed pollens based on the patient's sensitization profile and regional pollen exposure.
Dose escalation phase
Gradually increasing doses of allergen extract are administered over weeks to months to build immune tolerance without triggering significant allergic reactions.
Maintenance and long-term tolerance
Once the maintenance dose is reached, continued treatment for 3–5 years consolidates immune tolerance; most patients experience sustained benefit for years after treatment completion.
“Clinical trials in weed pollen-allergic populations demonstrate 60–80% reduction in symptom scores and medication requirements with allergen immunotherapy”
Treat your Palmer's Amaranth allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Palmer's Amaranth Pollen Allergy
Living with Palmer's amaranth pollen allergy in an endemic region requires a strategic, proactive approach — but with the right combination of environmental controls, pharmacotherapy, and immunotherapy, most patients achieve excellent symptom control and maintain a normal quality of life during the fall season. The key is recognizing that this is a marathon, not a sprint: the August–November pollen season is one of the longest continuous weed pollen exposures in North America, and treatment must be sustained accordingly. Patients in agricultural regions face the highest exposure and should develop a personalized action plan with their allergist that includes pre-season medication initiation, a clear step-up plan for high-count days, and objective criteria for when to consider immunotherapy. Keeping a symptom diary during the first season of treatment helps identify which interventions are most effective and whether additional therapy escalation is needed. For patients pursuing immunotherapy, the long-term outlook is excellent — most achieve substantial, sustained symptom reduction and significantly decreased medication dependence within the first year of treatment.
Develop a pre-season action plan
Work with your allergist to establish a written plan that specifies when to start controller medications, how to escalate therapy on high-count days, and objective criteria for considering immunotherapy.
Optimize your indoor environment
Invest in high-efficiency HVAC filters (MERV 11–13), a bedroom HEPA air purifier, and allergen-proof pillow and mattress covers to create a pollen-free sleep sanctuary during the fall season.
Track your symptoms and pollen counts
Use a symptom diary app alongside regional pollen count data to identify your personal exposure thresholds and objectively assess whether your current treatment regimen is adequate.
When Does Palmer's Amaranth Pollen Peak?
Palmer's amaranth is a classic late-summer and fall pollinator, with its season extending longer than most other weed pollens. Pollen release typically begins in August as plants mature and continues through November in warmer regions, with peak counts occurring in September and October. In the hottest areas of the Southwest (southern Arizona, the Rio Grande Valley), the season may extend into December if frost arrives late. The plant's biology amplifies its clinical impact: Palmer's amaranth is a C4 plant adapted to high temperatures and drought, meaning it thrives when many other plants are stressed — and it continues pollinating through the hottest, driest parts of late summer. The tumbleweed dispersal mechanism further extends exposure, as detached plants rolling across fields and roads release residual pollen even after the plant has senesced. For allergy patients in affected regions, this creates one of the longest continuous weed pollen seasons in North America, overlapping with ragweed season in many areas and extending the fall allergy burden well beyond the first frost.
August - September
high intensity
October - November
medium intensity
Preventing Palmer's Amaranth Pollen Reactions
Preventing Palmer's amaranth pollen reactions requires a proactive, multi-layered approach that begins before the August pollen season starts. Because the plant is a wind-pollinated tumbleweed that produces enormous pollen loads, complete avoidance is impossible in endemic regions — but strategic environmental controls can meaningfully reduce exposure. Indoor air quality management is the cornerstone of prevention: keeping windows and doors closed during the August–November season, using air conditioning with high-efficiency MERV 11–13 or HEPA filters, and running a standalone HEPA air purifier in the bedroom significantly reduces indoor pollen concentrations. After outdoor activities — particularly on windy days when tumbleweeds are dispersing — showering, washing hair, and changing clothes removes pollen that would otherwise be transferred to bedding and furniture. For patients in agricultural regions, tracking local pollen counts through the National Allergy Bureau or regional monitoring stations allows for activity planning around low-count days. Pre-season initiation of intranasal corticosteroids 1–2 weeks before the expected onset of amaranth pollen release reduces the severity of the initial inflammatory response and provides better symptom control throughout the season.
Monitor regional pollen counts
Use the National Allergy Bureau or local weather service pollen forecasts to identify high-count Palmer's amaranth days and plan indoor activities accordingly.
Seal your indoor environment
Keep windows and doors closed during the August–November pollen season; use air conditioning with high-efficiency filtration and consider a bedroom HEPA air purifier.
Decontaminate after outdoor exposure
Shower, wash hair, and change clothes after spending time outdoors — especially on windy days when tumbleweed pollen is airborne — to prevent ongoing indoor exposure.
Start medications before the season
Beginning intranasal corticosteroids 1–2 weeks before the expected onset of amaranth pollen release primes the nasal mucosa and reduces the severity of the initial inflammatory response.
Wear wraparound sunglasses outdoors
Physical barriers reduce pollen contact with the conjunctiva and can significantly decrease ocular symptoms during peak exposure periods.
Outlook for Palmer's Amaranth Pollen Allergy
The prognosis for Palmer's amaranth pollen allergy is generally favorable with appropriate management. Pharmacotherapy — particularly the combination of intranasal corticosteroids and second-generation antihistamines — provides adequate symptom control for most patients with mild-to-moderate disease. For those with severe, pharmacotherapy-refractory symptoms, allergen immunotherapy offers a disease-modifying treatment with 60–80% long-term symptom reduction and sustained benefit after treatment completion. The expanding geographic range of herbicide-resistant Palmer's amaranth means that this allergen is likely to become clinically relevant in regions where it was previously absent. However, increased awareness among allergists and the availability of amaranth extracts for testing and immunotherapy mean that most affected patients can be accurately diagnosed and effectively treated. The absence of systemic anaphylaxis risk from pollen exposure is reassuring — the primary challenges are symptom severity and season duration, both of which are manageable with current treatment modalities.
Key takeaways
Palmer's amaranth is one of the most clinically significant fall weed pollen allergens in the US Southwest, Southern Plains, and increasingly the Southeast
The August–November pollen season is among the longest continuous weed pollen exposures in North America, requiring sustained rather than intermittent treatment
High cross-reactivity within the Amaranthaceae family means patients are often co-sensitized to Russian thistle, lamb's quarters, and other related weeds
Allergen immunotherapy provides 60–80% long-term symptom reduction and is the only disease-modifying treatment for amaranth pollen allergy
Diet and Palmer's Amaranth Cross-Reactivity
Dietary cross-reactivity is a relevant consideration for patients sensitized to Palmer's amaranth, primarily through the profilin allergen Ama r 2. Profilin is a pan-allergen found throughout the plant kingdom, and patients with profilin sensitization may experience oral allergy syndrome — tingling, itching, or mild swelling of the lips, mouth, and throat — when eating raw plant foods that contain profilins. Commonly implicated foods include melons, watermelon, celery, kiwi, and stone fruits. These reactions are typically mild and self-limited, resolving within 15–30 minutes without treatment. Cooking denatures profilin, so cooked or processed versions of the same foods are usually well tolerated. The clinical significance of profilin-mediated food reactions varies among individuals and should be discussed with an allergist. Amaranth grain (a gluten-free pseudocereal from Amaranthus cruentus and other cultivated species) is not known to cross-react with Amaranthus pollen allergens and is generally safe for pollen-allergic patients.
Foods to limit
Raw melons and watermelon (profilin-sensitized patients)
Profilin cross-reactivity (Ama r 2) may cause oral tingling and lip swelling; cooked or processed melon products are typically tolerated.
Raw celery (profilin-sensitized patients)
Celery contains profilin proteins that cross-react with amaranth profilin Ama r 2; cooking denatures profilin and usually resolves reactivity.
Raw stone fruits (profilin-sensitized patients)
Peach, nectarine, and plum profilins may trigger oral allergy syndrome in patients with amaranth profilin sensitization; peeled and cooked fruits are typically safe.
Frequently Asked Questions
Palmer's amaranth (Amaranthus palmeri) and common pigweed (Amaranthus retroflexus) are closely related species in the same genus, and their pollen allergens are highly cross-reactive — meaning sensitization to one typically confers reactivity to the other. The clinical difference lies primarily in pollen output and geographic distribution. Palmer's amaranth is a far more aggressive and prolific pollen producer, with individual male plants releasing hundreds of thousands of pollen grains, and it has become the dominant Amaranthus species across much of the southern US due to herbicide resistance. Common pigweed is more widely distributed across North America but produces less pollen per plant. For practical purposes, a patient sensitized to either species will react to both, and immunotherapy extracts typically contain a mix of Amaranthus species to provide broad coverage.
Medical References
- [1]Würtzen PA, Nelson HS, Løwenstein H, Ipsen H. Characterization of Chenopodiales (Amaranthus retroflexus, Chenopodium album, Kochia scoparia, Salsola pestifer) pollen allergens. Allergy 1995;50(6):489–497.
- [2]Weber RW. Allergen of the Month — Carelessweed. Ann Allergy Asthma Immunol 2014;112(3):A11.
- [3]Gadermaier G, Hauser M, Ferreira F. Allergens of weed pollen: an overview on recombinant and natural molecules. Methods 2014;66(1):55–66.
- [4]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62(9):976–990.
- [5]Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127(1 Suppl):S1–S55.
- [6]Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8–160.
- [7]Ward SM, Webster TM, Steckel LE. Palmer amaranth (Amaranthus palmeri): a review. Weed Technology 2013;27(1):12–27.
- [8]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [9]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Palmer's Amaranth allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.
